Literature DB >> 29170098

Serum Activity of Macrophage-Derived Adenosine Deaminase 2 Is Associated With Liver Fibrosis in Nonalcoholic Fatty Liver Disease.

Z Gordon Jiang1, Bynvant Sandhu2, Linda Feldbrügge3, Eric U Yee4, Eva Csizmadia2, Shuji Mitsuhashi2, Jinhe Huang2, Nezam H Afdhal2, Simon C Robson2, Michelle Lai2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29170098      PMCID： PMC5962372          DOI： 10.1016/j.cgh.2017.11.028

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  8 in total

Review 1.  Purinergic signaling during inflammation.

Authors:  Holger K Eltzschig; Michail V Sitkovsky; Simon C Robson
Journal:  N Engl J Med       Date:  2012-12-13       Impact factor: 91.245

2.  Early-onset stroke and vasculopathy associated with mutations in ADA2.

Authors:  Qing Zhou; Dan Yang; Amanda K Ombrello; Andrey V Zavialov; Camilo Toro; Anton V Zavialov; Deborah L Stone; Jae Jin Chae; Sergio D Rosenzweig; Kevin Bishop; Karyl S Barron; Hye Sun Kuehn; Patrycja Hoffmann; Alejandra Negro; Wanxia L Tsai; Edward W Cowen; Wuhong Pei; Joshua D Milner; Christopher Silvin; Theo Heller; David T Chin; Nicholas J Patronas; John S Barber; Chyi-Chia R Lee; Geryl M Wood; Alexander Ling; Susan J Kelly; David E Kleiner; James C Mullikin; Nancy J Ganson; Heidi H Kong; Sophie Hambleton; Fabio Candotti; Martha M Quezado; Katherine R Calvo; Hawwa Alao; Beverly K Barham; Anne Jones; James F Meschia; Bradford B Worrall; Scott E Kasner; Stephen S Rich; Raphaela Goldbach-Mansky; Mario Abinun; Elizabeth Chalom; Alisa C Gotte; Marilynn Punaro; Virginia Pascual; James W Verbsky; Troy R Torgerson; Nora G Singer; Timothy R Gershon; Seza Ozen; Omer Karadag; Thomas A Fleisher; Elaine F Remmers; Shawn M Burgess; Susan L Moir; Massimo Gadina; Raman Sood; Michael S Hershfield; Manfred Boehm; Daniel L Kastner; Ivona Aksentijevich
Journal:  N Engl J Med       Date:  2014-02-19       Impact factor: 91.245

3.  Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity.

Authors:  Andrey V Zavialov; Ake Engström
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

4.  Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.

Authors:  Paulina Navon Elkan; Sarah B Pierce; Reeval Segel; Tom Walsh; Judith Barash; Shai Padeh; Abraham Zlotogorski; Yackov Berkun; Joseph J Press; Masha Mukamel; Isabel Voth; Philip J Hashkes; Liora Harel; Vered Hoffer; Eduard Ling; Fatos Yalcinkaya; Ozgur Kasapcopur; Ming K Lee; Rachel E Klevit; Paul Renbaum; Ariella Weinberg-Shukron; Elif F Sener; Barbara Schormair; Sharon Zeligson; Dina Marek-Yagel; Tim M Strom; Mordechai Shohat; Amihood Singer; Alan Rubinow; Elon Pras; Juliane Winkelmann; Mustafa Tekin; Yair Anikster; Mary-Claire King; Ephrat Levy-Lahad
Journal:  N Engl J Med       Date:  2014-02-19       Impact factor: 91.245

5.  Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma.

Authors:  Z Gordon Jiang; Yan Wu; Eva Csizmadia; Linda Feldbrügge; Keiichi Enjyoji; John Tigges; Vasilis Toxavidis; Holger Stephan; Christa E Müller; Christina E Müller; C James McKnight; Alan Moss; Simon C Robson
Journal:  Purinergic Signal       Date:  2014-08-28       Impact factor: 3.765

6.  Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.

Authors:  Zhenghui G Jiang; Elliot B Tapper; Margery A Connelly; Carolina F M G Pimentel; Linda Feldbrügge; Misung Kim; Sarah Krawczyk; Nezam Afdhal; Simon C Robson; Mark A Herman; James D Otvos; Kenneth J Mukamal; Michelle Lai
Journal:  Liver Int       Date:  2016-02-24       Impact factor: 5.828

7.  Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.

Authors:  Konstantin Kazankov; Francisco Barrera; Holger Jon Møller; Bo Martin Bibby; Hendrik Vilstrup; Jacob George; Henning Grønbaek
Journal:  Hepatology       Date:  2014-05-06       Impact factor: 17.425

Review 8.  Macrophages During the Fibrotic Process: M2 as Friend and Foe.

Authors:  Tarcio Teodoro Braga; Juan Sebastian Henao Agudelo; Niels Olsen Saraiva Camara
Journal:  Front Immunol       Date:  2015-11-25       Impact factor: 7.561
  8 in total
  6 in total

1.  Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division.

Authors:  Jin Rong Ow; Matias J Cadez; Gözde Zafer; Juat Chin Foo; Hong Yu Li; Soumita Ghosh; Heike Wollmann; Amaury Cazenave-Gassiot; Chee Bing Ong; Markus R Wenk; Weiping Han; Hyungwon Choi; Philipp Kaldis
Journal:  Elife       Date:  2020-12-21       Impact factor: 8.140

2.  Adenosine deaminase 2 produced by infiltrative monocytes promotes liver fibrosis in nonalcoholic fatty liver disease.

Authors:  Shilpa Tiwari-Heckler; Eric U Yee; Yusuf Yalcin; Jiwoon Park; Duc-Huy T Nguyen; Wenda Gao; Eva Csizmadia; Nezam Afdhal; Kenneth J Mukamal; Simon C Robson; Michelle Lai; Robert E Schwartz; Z Gordon Jiang
Journal:  Cell Rep       Date:  2021-10-26       Impact factor: 9.423

Review 3.  Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update.

Authors:  Jawaher Alharthi; Mohammed Eslam
Journal:  J Clin Transl Hepatol       Date:  2021-10-13

4.  ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer.

Authors:  Wenwen Luo; Liang Dong; Fenghong Chen; Wenbin Lei; Liya He; Qing Zhou; Thierry Lamy; Andrey V Zavialov
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 5.  Macrophages in metabolic associated fatty liver disease.

Authors:  Jawaher Alharthi; Olivier Latchoumanin; Jacob George; Mohammed Eslam
Journal:  World J Gastroenterol       Date:  2020-04-28       Impact factor: 5.742

Review 6.  Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.

Authors:  Pietro Torre; Benedetta Maria Motta; Roberta Sciorio; Mario Masarone; Marcello Persico
Journal:  Front Med (Lausanne)       Date:  2021-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.